Literature DB >> 12493410

The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.

T Pisitkun1, S Eiam-Ong, S Chusil, K Praditpornsilpa, P Pansin, K Tungsanga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12493410     DOI： 10.1016/s0041-1345(02)03684-9

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.

Authors:  Katherine A Barraclough; Nicole M Isbel; Carl M Kirkpatrick; Katie J Lee; Paul J Taylor; David W Johnson; Scott B Campbell; Diana R Leary; Christine E Staatz
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

2.  A limited sampling strategy to estimate exposure of once-daily modified release tacrolimus in renal transplant recipients using linear regression analysis and comparison with Bayesian population pharmacokinetics in different cohorts.

Authors:  Frank Stifft; Franciscus Vandermeer; Cees Neef; Sander van Kuijk; Maarten H L Christiaans
Journal:  Eur J Clin Pharmacol       Date:  2020-02-04       Impact factor: 2.953

Review 3.  Once- versus twice-daily tacrolimus: are the formulations truly equivalent?

Authors:  Katherine A Barraclough; Nicole M Isbel; David W Johnson; Scott B Campbell; Christine E Staatz
Journal:  Drugs       Date:  2011-08-20       Impact factor: 9.546

4.  Evaluation of limited sampling strategies for tacrolimus.

Authors:  Robert A M Op den Buijsch; Afke van de Plas; Leo M L Stolk; Maarten H L Christiaans; Johannes P van Hooff; Nas A Undre; Marja P van Dieijen-Visser; Otto Bekers
Journal:  Eur J Clin Pharmacol       Date:  2007-08-22       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Evaluation of tacrolimus abbreviated area-under-the-curve monitoring in renal transplant patients who are potentially at risk for adverse events.

Authors:  Yuen Yi Hon; Christine E Chamberlain; David E Kleiner; Michael S Ring; Douglas A Hale; Allan D Kirk; Roslyn B Mannon
Journal:  Clin Transplant       Date:  2010 Jul-Aug       Impact factor: 2.863

7.  Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants.

Authors:  Seung Seok Han; Do Hyoung Kim; Su Mi Lee; Na Young Han; Jung Mi Oh; Jongwon Ha; Yon Su Kim
Journal:  Kidney Res Clin Pract       Date:  2012-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.